$50.00
-0.02-0.04%
Last update: Oct 23, 7:20 PM
Eton Pharmaceuticals Inc (ETON) Stock Price, Quote, News & History
ETONNASDAQ
Eton Pharmaceuticals licenses Aquestive’s LIBERVANT buccal film for U.S. seizure cluster treatment, with launch set for April 2027.
You can purchase shares of Eton Pharmaceuticals (NASDAQ:ETON) through any online brokerage.
Other companies in Eton Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Eton Pharmaceuticals has a consensus price target of $56.00.
The stock price for Eton Pharmaceuticals (NASDAQ: ETON) is $49.44 last updated October 23, 2026 at 7:20 PM EDT.
There are no upcoming dividends for Eton Pharmaceuticals.
Eton Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Eton Pharmaceuticals.
Eton Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products,...
